Why the study?
Do elevated serum endocan levels predict death or major disability in patients with acute ischemic stroke?
Population
227 patients with acute ischemic stroke
Comparison
Highest quartile of serum endocan levels vs Lowest quartile of serum endocan levels
Design
Cohort
Follow-up
3 months
Authors
Loading...
Elevated serum endocan levels are independently associated with an increased risk of death or major disability at 3 months after acute ischemic stroke.
Do elevated serum endocan levels predict death or major disability in patients with acute ischemic stroke?
Elevated serum endocan levels are independently associated with an increased risk of death or major disability at 3 months after acute ischemic stroke.
Han et al. (2021) studied this question.